Innoviva, Inc. Common Stock

INVA XNAS PHARMACEUTICAL PREPARATIONS

Market Cap

1.6B

Short interest (Jul 15)

9.5%

Net Short (Jul 27 ): 0.0%

Borrow Fee

0.36%

Available Shares

4M

Price Chart

Company Overview

Innoviva Inc is a company with a portfolio of royalty healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Trelegy, and others.

Company Info

Exchange: NASDAQ
Industry: PHARMACEUTICAL PREPARATIONS
CIK: 0001080014
Asset Type: CS

Market Data

Market Cap: $1,582,459,578
Employees: 159
Status: Active

Short Interest

Current Borrow Fee 0.36%
Range: 0.36% - 0.36%
Available Shares 4M
Range: 2.8M - 3.5M

Recent Changes

Quick Actions

View Dilution Chart
Add to Watchlist Set Price Alert View Options Chain

Investment Risk

This is not financial advice. All investments carry risk. Do your own research before making investment decisions.

Weekly Research

Get Weekly Super Stonk Alerts

Never miss a squeeze opportunity. Get our weekly analysis of high short interest stocks, AI-discovered gems, and dilution warnings delivered to your inbox.

No spam Unsubscribe anytime